leucodin has been researched along with 3-methylquercetin in 2 studies
| Studies (leucodin) | Trials (leucodin) | Recent Studies (post-2010) (leucodin) | Studies (3-methylquercetin) | Trials (3-methylquercetin) | Recent Studies (post-2010) (3-methylquercetin) |
|---|---|---|---|---|---|
| 26 | 0 | 15 | 464 | 16 | 269 |
| Protein | Taxonomy | leucodin (IC50) | 3-methylquercetin (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.056 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 1.261 | |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 2.51 | |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | 6.3 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 6.3 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 0.017 | |
| Inositol polyphosphate multikinase | Homo sapiens (human) | 2.2 | |
| Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | 5 | |
| 3-oxoacyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | 8.3 | |
| Aurora kinase B | Homo sapiens (human) | 4.34 | |
| Inositol hexakisphosphate kinase 2 | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Emami, SA; Taleghani, A; Tayarani-Najaran, Z | 1 |
1 review(s) available for leucodin and 3-methylquercetin
| Article | Year |
|---|---|
Artemisia: a promising plant for the treatment of cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Artemisia; Cell Proliferation; Humans; Molecular Structure; Neoplasms; Neoplasms, Experimental; Plant Extracts; Plants, Medicinal | 2020 |
1 other study(ies) available for leucodin and 3-methylquercetin
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |